BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Nov 27, 2025; 17(11): 109494
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.109494
Explainable artificial intelligence and ensemble learning for hepatocellular carcinoma classification: State of the art, performance, and clinical implications
Sami Akbulut, Cemil Colak
Sami Akbulut, Surgery and Liver Transplantation, Inonu University Faculty of Medicine, Malatya 44280, Türkiye
Sami Akbulut, Cemil Colak, Biostatistics and Medical Informatics, Inonu University Faculty of Medicine, Malatya 44280, Türkiye
Author contributions: Akbulut S and Colak C conceived the project and designed research, wrote the manuscript and reviewed final version
Conflict-of-interest statement: The authors declare no competing interests.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sami Akbulut, MD, FACS, Professor, Surgery and Liver Transplantation, Inonu University Faculty of Medicine, Elazig Yolu 10 Km, Malatya 44280, Türkiye. akbulutsami@gmail.com
Received: May 13, 2025
Revised: June 13, 2025
Accepted: October 10, 2025
Published online: November 27, 2025
Processing time: 198 Days and 11.2 Hours
Core Tip

Core Tip: Explainable artificial intelligence (XAI) seeks to improve the interpretability and transparency of machine learning models in healthcare settings. In this context, Explainable Ensemble Learning, a fundamental strategy within XAI, integrates multiple models, including Random Forest, Extreme Gradient Boosting, and Stacking, to improve classification performance in hepatocellular carcinoma (HCC). Despite their high predictive accuracy, the inherent "black-box" feature of ensemble methods remains a barrier to clinical practice. XAI techniques—such as SHapley Additive exPlanations, Local Interpretable Model-agnostic Explanations, and Gradient-weighted Class Activation Mapping—clarify model predictions, fostering medical trust and interpretability. By combining clinical, genetic, and imaging data with XAI frameworks, diagnosis, staging, and prognosis of HCC can be improved, ultimately supporting transparent and reliable decision-making in healthcare. Future research should focus on model interpretability, data integration, and user-friendly clinical interfaces.